drugset / Trial / NCT02151591
New Approaches to Smoking Cessation in Heavy Drinkers
Phase 1
Completed
26 enrolled
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to develop and test an integrated cognitive-behavioral intervention for smoking and alcohol among heavy drinking smokers. The current pre-pilot phase will be used to refine this protocol for the subsequent randomized, controlled pilot phase. The current study phase has two parts: 1) an intake session and brief physical; 2) a 12-week treatment phase in which participants receive varenicline (Chantix) and weekly, personalized counseling.
Timeline
- Start
- 2017-03-01
- Primary completion
- 2018-06-01
- Completion
- 2018-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Varenicline | Small molecule | 1 mg | — |